Emergent Biosolutions Inc

FDA Filings

This page includes the latest FDA filings for Emergent Biosolutions Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

USA

NEW YORK STOCK EXCHANGE

FDA Registration(s)

FDA Filings

Device Company	Device	Date
Fusilev Acrotech Biopharma LLC, Emergent BioSolutions, Inc.	Prescription Medication	2024-05-18
Fusilev Acrotech Biopharma LLC, Emergent BioSolutions, Inc.	Prescription Medication	2024-04-18
Fusilev Acrotech Biopharma LLC, Emergent BioSolutions, Inc.	Prescription Medication	2023-03-06
Fusilev Acrotech Biopharma LLC, Emergent BioSolutions, Inc.	Prescription Medication	2020-11-25
Fusilev Acrotech Biopharma LLC, Emergent BioSolutions, Inc.	Prescription Medication	2020-02-26
Fusilev Acrotech Biopharma LLC, Emergent BioSolutions, Inc.	Prescription Medication	2020-01-24
Fusilev Acrotech Biopharma LLC, Emergent BioSolutions, Inc.	Prescription Medication	2019-10-15

Similar & Related FDA Registered Companies

Related Finance Registrations

NCAGE Code	54KE5	EMERGENT BIOSOLUTIONS INC.
CAGE Code	54KE5	EMERGENT BIOSOLUTIONS INC.
SEC	0001367644	Emergent BioSolutions Inc. of DELAWARE

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.